Conclusion
This study suggests the potential use of GD as a treatment in relapsed metastatic/locally advanced unresectable SS, especially in populations lacking access to, or ineligible for novel therapeutic options. Collaborative efforts are warranted in the future to assess the efficacy of this regimen in a larger cohort of patients.